Search results
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 7 days agovaccine developer is also eligible to receive royalties and up to $700 million in milestone revenue...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 2 days agoSanofi will pay $500 million up front to Novavax for the right to co-commercialize Nuvaxovid...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 4 days agoThe review is now expected to be completed by the end of this month. The FDA, however, did not...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 6 days agovaccine has demonstrated strong protection to date, and we will be interested to see if mRNA ...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 6 days agovaccine in partnership with Merck. The shot prompts an immune response against a patient's own tumor...
3 Cheap Biotech Stocks to Buy Now: May 2024
InvestorPlace· 7 days agoThe biotech industry is notably risky, but can produce stocks that see massive gains within a day. Well, many of these companies depend on FDA approval...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...